ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 215 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $250,000 | -33.3% | 4,670 | +40.8% | 0.02% | -11.1% |
| Q4 2015 | $375,000 | -86.6% | 3,317 | -86.0% | 0.02% | -87.0% |
| Q3 2015 | $2,798,000 | +353.5% | 23,772 | +198.4% | 0.14% | +475.0% |
| Q2 2015 | $617,000 | +176.7% | 7,966 | +15.4% | 0.02% | +50.0% |
| Q4 2014 | $223,000 | -50.4% | 6,905 | -62.4% | 0.02% | -33.3% |
| Q3 2014 | $450,000 | +112.3% | 18,376 | +53.4% | 0.02% | +140.0% |
| Q2 2014 | $212,000 | +15.8% | 11,976 | +9.7% | 0.01% | -28.6% |
| Q4 2013 | $183,000 | – | 10,918 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |